The Latest Breaking News from Moderna

Moderna said it's moving ahead with an omicron-specific booster shot on Wednesday. The news prodded Moderna stock higher.

Moderna Inc (NASDAQ: MRNA) shares are trading higher by 7.2% at $163.54 Wednesday afternoon after Deutsche Bank upgraded the stock from Sell to Hold and announced a $175 price target.

Crude oil futures dipped more than 2% on Monday as the US dollar strengthened following increasing concerns between the US and Russia over Ukraine. Investors, meanwhile, focused on some notable insider trades.

The two most successful coronavirus vaccines developed in the U.S. – the Pfizer and Moderna vaccines – are both mRNA vaccines. The idea of using genetic material to produce an immune response has opened up a world of research and potential medical uses far out of reach of traditional vaccines.…

A whale with a lot of money to spend has taken a noticeably bullish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 18 strange trades.

 

Saudi Arabia’s Ministry of Hajj and Umrah has decided that travelers inbound to the Kingdom who have received a full dose of one of the approved vaccines, including Oxford-AstraZeneca, Pfizer-BioNTech, Johnson & Johnson, Moderna, are exempt from the need to quarantine. In a statement to Asharq Al-Awsat, the Ministry revealed…

Public Storage (NYSE: PSA) helps organize and store your belongings, and over the past year delivered astonishing returns.

Moderna is aiming to launch a single vaccine that will offer protection against flu and Covid. During the booster roll out, those who were offered a flu jab were also offered a booster on the same day.